DelAversano Robert J 4
4 · ONCOSEC MEDICAL Inc · Filed Feb 9, 2023
Insider Transaction Report
Form 4
DelAversano Robert J
Principal Accounting Officer
Transactions
- Sale
Common Stock
2023-02-09$1.37/sh−40$55→ 1,008 total
Footnotes (2)
- [F1]In connection with the vesting of 49 RSUs on February 1, 2023, a total of 40 shares were sold in order to satisfy the reporting person's tax withholding obligations. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies.
- [F2]Effective as of 12:01 a.m. Eastern Time on November 9, 2022, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-22.